2 2021 Annual Conference | Thrombosis Canada – Thrombose Canada
Go to Top

2021 Annual Conference

Co-chairs
Lana Castellucci Hematology; Co-chair MD, FRCPC, MSc
Eric Tseng Hematology; Co-chair MD, MScCH, FRCPC
Committee Members:
Jameel Abdulrehman Hematology MD, FRCPC
Julia Bayadinova NP, Thrombosis NP-PHC, MN
Ania Bekasiak Family Medicine MD
Leonardo Brandão Pediatric hematology MD
Timothy Chan Internal Medicine MD, FRCPC
Tamer Elias Pharmacist PharmD, BCGP, RPh
Karen Moffat Coagulation Lab BEd, MSc, ART, FCSMLS(D)
Joseph Shaw Hematology Fellow MD, FRCPC

OVERALL MEETING OBJECTIVES

After completing this program, participants will be equipped to:

  • Apply current evidence in the management of patients with thrombotic disease
  • Manage thrombosis challenges in face-to-face and virtual clinical practice effectively
  • Describe thrombosis prophylaxis and treatment in patients affected by COVID-19
  • Implement thrombosis treatment options in a variety of patient populations

ACCREDITATION

This Group Learning program has been certified by the College of Family Physicians of Canada and the Ontario Chapter for up to 5.50  Mainpro+ credits.

  The Canadian Council on Continuing Education in Pharmacy has accredited this program for 10.75 CEUs.
Le Conseil canadien de l’éducation continue en pharmacie a octroyé 10.75 crédits de formation continue pour ce programme.

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the University of Ottawa’s Office of Continuing Professional Development. You may claim a maximum of 5.5 hours (credits are automatically calculated).

AGENDA

Time Topic Speakers
7:30 – 8:30 Sponsored Breakfast Symposium:
Cancer-associated thrombosis: What’s new?
Marc Carrier
Vicky Tagalakis
Jeff Habert
Cynthia Wu
8:45 – 9:00 Conference opening remarks Lana Castellucci
Eric Tseng
9:00 – 9:30 Transgender/hormonal therapy and VTE risks Jean Connors
9:30 – 10:00 DOACs in adolescents Leonardo Brandão
10:00 – 10:30 Management of anticoagulant-associated heavy menstrual bleeding Joseph Shaw
10:30 – 10:45 BREAK
10:45 – 11:15 CVA and anti-thrombotics Thalia Field
11:15 – 11:45 Core labs and anticoagulant use Karen Moffat
11:45 – 12:15 Virtual thrombosis management Timothy Chan
12:15 – 13:15 LUNCH (with short presentation from TC fellowship recipient)
13:15 – 13:45 Covid: Anticoagulation in hospitalized patients Vicky Tagalakis
13:45 – 14:15 Covid 2: VITT Menaka Pai
14:15 – 14:30 BREAK                                                                                        Facilitators                     
Each workshop is run twice:

 

14:30 – 15:15

and

15:15 – 16:00

Pediatric topic Leonardo Brandão
Mihir Bhatt
Extended VTE prophylaxis: post-hospitalization and post unprovoked VTE Peter Gross
Rick Ikesaka
Unusual site VTE: splanchnic vein, retinal vein, cerebral vein, others Zach Liederman
Alejandro Lazo-Langner
ASA for primary prevention and PAD Alan Bell
Vera Dounaevskaia
Bleeding management and resuming anticoagulation; tricky INRs Rita Selby
Deb Siegal
Perioperative management Joseph Shaw
Julia Bayadinova
Women’s health/pregnancy/VTE Carolyne Elbaz
Isabelle Malhamé
Special populations; elderly, obese, CKD, renal Timothy Chan
Jameel Abdulrehman
Emergency management of VTE in the ED Kerstin de Wit
Lana Castellucci

Click here for more information and to register to attend: 2021 Conference Registration

This program is supported by educational grants from Alexion Canada, Bayer Inc., BMS-Pfizer, LEO Pharma, Pfizer Hospital, Sanofi and Servier Canada